MedPath

Linagliptin and Metformin

Generic Name
Linagliptin and Metformin
Brand Names
-
Drug Type
-
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
-
Indication

用于治疗成年患者2型糖尿病:利格列汀二甲双胍片,配合饮食和运动,用于经二甲双胍单药治疗血糖仍控制不佳或正在接受二者联合治疗患者。利格列汀二甲双胍片与磺脲类药物联合治疗,配合饮食和运动,治疗成年患者二甲双胍和磺脲类药物联合治疗不佳。利格列汀二甲双胍片与胰岛素联合治疗,配合饮食和运动,治疗成年患者二甲双胍和胰岛素联合治疗不佳。

Associated Conditions
-
Associated Therapies
-

Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD

Phase 4
Recruiting
Conditions
Nonalcoholic Fatty Liver Disease
Type2 Diabetes Mellitus
Interventions
Drug: Henagliflozein and Metformin
Drug: Linagliptin and Metformin
First Posted Date
2024-06-10
Last Posted Date
2024-06-10
Lead Sponsor
Zhujiang Hospital
Target Recruit Count
100
Registration Number
NCT06449833
Locations
🇨🇳

Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong, China

A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea

Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
First Posted Date
2013-07-19
Last Posted Date
2018-12-21
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
724
Registration Number
NCT01903356
© Copyright 2025. All Rights Reserved by MedPath